HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert E Ratner Selected Research

BIM 51077

7/2009Treatment with the human once-weekly glucagon-like peptide-1 analog taspoglutide in combination with metformin improves glycemic control and lowers body weight in patients with type 2 diabetes inadequately controlled with metformin alone: a double-blind placebo-controlled study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert E Ratner Research Topics

Disease

24Type 2 Diabetes Mellitus (MODY)
11/2018 - 01/2002
13Hypoglycemia (Reactive Hypoglycemia)
01/2018 - 01/2002
11Atherosclerosis
11/2018 - 11/2006
9Insulin Resistance
01/2016 - 12/2003
8Glucose Intolerance
05/2015 - 12/2003
6Weight Loss (Weight Reduction)
01/2022 - 05/2005
6Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2015 - 01/2004
6Cardiovascular Diseases (Cardiovascular Disease)
10/2014 - 12/2003
6Weight Gain
03/2011 - 12/2004
4Prediabetic State (Prediabetes)
01/2020 - 04/2011
4Body Weight (Weight, Body)
05/2014 - 01/2002
3Dyslipidemias (Dyslipidemia)
10/2014 - 02/2013
3Inflammation (Inflammations)
02/2013 - 12/2003
3Hyperglycemia
02/2013 - 11/2006
3Coronary Artery Disease (Coronary Atherosclerosis)
03/2012 - 12/2008
3Ischemia
04/2009 - 08/2004
2Gestational Diabetes (Gestational Diabetes Mellitus)
11/2018 - 12/2008
2Chronic Renal Insufficiency
10/2014 - 10/2014
2Hypertension (High Blood Pressure)
10/2014 - 10/2014
2Nausea
08/2014 - 01/2002
2Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2013 - 04/2011
1Ketosis
01/2022
1Vomiting
08/2014
1Injection Site Reaction
08/2014
1Neoplasms (Cancer)
01/2014
1Neointima
03/2012
1Pathologic Constriction (Stenosis)
03/2012
1Hyperplasia
03/2012
1Polyneuropathies (Polyneuropathy)
04/2011
1Edema (Dropsy)
03/2011
1Atherosclerotic Plaque (Atheroma)
03/2010
1Schizophrenia (Dementia Praecox)
04/2009
1Carotid Artery Diseases
12/2008
1Headache (Headaches)
11/2008

Drug/Important Bio-Agent (IBA)

16Glucose (Dextrose)FDA LinkGeneric
11/2018 - 09/2007
13Metformin (Glucophage)FDA LinkGeneric
01/2020 - 03/2005
13Insulin (Novolin)FDA Link
01/2018 - 01/2002
7oxidized low density lipoproteinIBA
11/2011 - 11/2005
6SandIBA
11/2011 - 11/2006
6LDL CholesterolIBA
05/2010 - 11/2005
4Pioglitazone (Actos)FDA Link
05/2015 - 03/2011
4LipidsIBA
11/2011 - 09/2007
4pramlintide (Symlin)FDA Link
11/2006 - 01/2002
3Insulin Glargine (Lantus)FDA Link
08/2014 - 03/2011
3Glipizide (Glucotrol)FDA LinkGeneric
03/2012 - 12/2008
3Rosiglitazone (Avandia)FDA Link
03/2012 - 12/2008
3ThiazolidinedionesIBA
04/2011 - 12/2003
32,4-thiazolidinedione (thiazolidinedione)IBA
03/2010 - 05/2008
3Glucagon-Like Peptide 1 (GLP 1)IBA
07/2009 - 03/2005
3Adenosine (Adenocard)FDA LinkGeneric
04/2009 - 08/2004
2Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
10/2014 - 10/2014
2AdiponectinIBA
06/2014 - 02/2013
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2009 - 12/2008
2Glucagon (Glukagon)FDA Link
10/2008 - 11/2006
2Hormones (Hormone)IBA
10/2008 - 01/2002
2IncretinsIBA
10/2008 - 05/2005
2Exenatide (Byetta)FDA Link
05/2008 - 05/2005
2Hypoglycemic Agents (Hypoglycemics)IBA
02/2007 - 12/2004
1CarbohydratesIBA
01/2022
1CalciumIBA
11/2018
15'-palmitoyl cytarabine (PLAC)IBA
01/2016
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
05/2015
1Insulin Lispro (Humalog)FDA Link
08/2014
1rGLP-1 proteinIBA
08/2014
1Glucagon-Like Peptide-1 ReceptorIBA
08/2014
1lixisenatideIBA
05/2014
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2014
1C-PeptideIBA
11/2013
1Hemoglobins (Hemoglobin)IBA
02/2013
1Plasminogen Activators (Plasminogen Activator)IBA
02/2013
1HDL CholesterolIBA
02/2013
1MetalsIBA
03/2012
1ReninIBA
04/2011
1calcium dependent sulfhydryl proteaseIBA
04/2011
1AcarboseFDA LinkGeneric
04/2011
1AngiotensinsIBA
04/2011
1Glucagon-Like Peptide-1 Receptor AgonistsIBA
04/2011
1insulin degludecIBA
03/2011
1Long-Acting Insulin (Insulin, Long Acting)FDA Link
03/2011
1Insulin Aspart (NovoLog)FDA Link
03/2011
1Phenobarbital (Luminal)FDA Link
03/2010
1Lipoproteins (Lipoprotein)IBA
10/2009
1Peptides (Polypeptides)IBA
09/2009
1Proteins (Proteins, Gene)FDA Link
09/2009
1taspoglutideIBA
07/2009
1BIM 51077IBA
07/2009
1Radioisotopes (Radionuclides)IBA
04/2009
1Quetiapine Fumarate (Seroquel)FDA Link
04/2009
1Risperidone (Risperdal Consta)FDA LinkGeneric
04/2009
1Olanzapine (Zyprexa)FDA Link
04/2009
1Ezetimibe (Zetia)FDA Link
12/2008
1SecretagoguesIBA
12/2008
1Sitagliptin Phosphate (Januvia)FDA Link
11/2008

Therapy/Procedure

12Therapeutics
11/2018 - 01/2002
10Glycemic Control
05/2014 - 12/2003
3Drug Therapy (Chemotherapy)
10/2014 - 04/2011
2Percutaneous Coronary Intervention
03/2010 - 12/2008
1Precision Medicine
10/2015
1Stents
03/2012
1Drug-Eluting Stents
03/2012